Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
Director departure
Appointed director
CC transcript
Auditor change
|
|
Vaxart, Inc. (VXRT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/11/2023 |
4/A
| Lee Phillip E (CFO) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Granted 45,000 shares
@ $0
Granted 56,652 shares
@ $0
Granted 205,000 options to buy
@ $0.78, valued at
$159.9k
|
|
| 06/14/2021 |
4/A
| Davis Todd C (Director) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Granted 54,720 options to buy
@ $0.31, valued at
$17k
|
|
| 06/14/2021 |
4/A
| Yedid Robert A. (Director) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Granted 54,720 options to buy
@ $0.31, valued at
$17k
|
|
| 02/06/2019 |
4/A
| Finney Michael J. (Director) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Granted 1,818 shares
@ $0 |
|
| 06/15/2015 |
4/A
| Fox James (Director) has filed a Form 4 on Biota Pharmaceuticals, Inc. |
| 05/06/2013 |
4/A
| Hill Richard James (Director) has filed a Form 4 on Biota Pharmaceuticals, Inc. |
| 05/06/2013 |
4/A
| Fox James (Director) has filed a Form 4 on Biota Pharmaceuticals, Inc. |
| 05/06/2013 |
4/A
| Cook Peter Chapman (Director) has filed a Form 4 on Biota Pharmaceuticals, Inc. |
| 12/29/2010 |
4/A
| Aryeh Jason (Director) has filed a Form 4 on NABI BIOPHARMACEUTICALS|
Txns:
| Sold 1,907 shares
@ $5.74, valued at
$10.9k
|
|
| 03/23/2010 |
4/A
| Aryeh Jason (Director) has filed a Form 4 on NABI BIOPHARMACEUTICALS |
|
|